🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Industrials Sector SEC Filings — July 28, 2026

The S&P 500 Industrials sector is presenting a mixed picture for Q2 2026, characterized by top-line growth across most companies but significant margin compression and earnings pressure. Revenue growth was broad-based, with Illinois Tool Works (+6.1% YoY), UPS (+7.5%), and Boeing (+8%) leading, while Waste Management and Carrier Global posted more modest gains. However, profitability is under severe strain: GAAP earnings fell sharply at UPS (EPS down 57%) and Carrier (down 14-15%), and Boeing continued to post losses, albeit narrowing. The primary driver of this divergence is a wave of restructuring and transformation charges, notably UPS's $891M charge and Boeing's persistent program losses, alongside rising input costs that outpaced pricing in some segments. Insider selling has been a notable and concentrated negative signal, particularly at RTX Corp where three senior executives and a director sold a combined ~$2.9M in stock. Capital allocation is bifurcated, with Illinois Tool Works returning a record $1.2B to shareholders, while Boeing's cash position deteriorated sharply post-Spirit AeroSystems acquisition. The key takeaway is that operational execution and cost control are now the critical differentiators, with companies like ITW demonstrating best-in-class margin management, while others face a challenging path to restoring profitability.

5 high priority 10 medium 15 total filings
· daily

US Material Events SEC 8-K Filings — July 28, 2026

The July 28, 2026, filing cycle reveals a market with significant capital reallocation and strategic pivots, but also notable leadership disruptions and financial distress. The most critical development is the sudden passing of Carpenter Technology's CEO, creating immediate leadership uncertainty in a key industrial supplier. Capital markets activity is robust, with several large-scale debt and equity transactions: Galaxy Digital's $3.5B data center financing, Conagra's $500M note offering, and Atlantic Union's $250M subordinated note issuance signal a strong appetite for corporate debt, while Entera Bio's $275M private placement highlights continued biotech funding. The healthcare sector shows a stark contrast, with Centene's operational turnaround (EPS swinging from -$0.51 to +$2.51) juxtaposed against American Shared Hospital Services' acknowledged default and forbearance agreement. A clear theme of 'capital for growth' emerges, with companies like Cadiz ($273.8M in construction contracts) and Core University Living ($303.5M acquisition) deploying significant capital into long-term infrastructure and real estate projects. However, the prevalence of dilutive financing structures (Polar Power's CEF and convertible preferred, T1 Energy's IP acquisition with stock-based payments) and the high number of routine officer changes (12+ filings) suggest a market in transition, where companies are aggressively positioning for the next cycle while managing legacy risks.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — July 28, 2026

The 16 filings from Dow 30 constituents reveal a mixed picture for the second quarter of 2026. While revenue growth is a common theme—with Coca-Cola, Sherwin-Williams, Boeing, and Visa all reporting YoY top-line increases—profitability and forward guidance are more cautious. Coca-Cola raised its full-year guidance, signaling confidence, but Sherwin-Williams and Boeing noted persistent demand softness and operational headwinds, respectively. The most significant corporate action is Johnson & Johnson's $5.5 billion talc litigation settlement, which removes a major legal overhang but introduces execution risk. Insider activity was largely neutral, consisting of routine stock-for-tax withholding by executives at Alphabet and gifts by JPMorgan executives, providing no strong directional signal. A key portfolio-level theme is the divergence between consumer-facing companies (Coca-Cola, Sherwin-Williams) showing volume growth and industrial/cyclical companies (Boeing) still grappling with losses, despite improving cash flows. Capital allocation is a clear differentiator, with Sherwin-Williams aggressively repurchasing shares while Boeing invests heavily in capex, highlighting contrasting strategies for returning value versus rebuilding the business.

4 high priority 12 medium 16 total filings
· daily

Global High-Priority Regulatory Events — July 28, 2026

This digest covers 50 filings from July 28, 2026, dominated by a wave of M&A, insolvency, and delisting events. A key theme is the aggressive consolidation in the Indian distressed asset market, with Authum Investment & Infrastructure and Inox Green Energy Services securing NCLT approval for the Wind World India resolution, while Astron Paper & Board Mill enters CIRP with a 99% revenue collapse. In the US, the take-private of Cross Country Healthcare by Knox Lane and ANV Group's acquisition of 81.37% of Open Lending highlight a trend of public-to-private transactions. The SPAC market shows bifurcation, with a new $200M IPO from Market Technology Acquisition Corp and a $115M IPO from Southern Cross Acquisition I Corp, contrasted by the failed $303M tender offer for Lisata Therapeutics by Kuva Labs. A significant cluster of 10 ETF delistings from Themes ETF Trust and ETF Opportunities Trust signals a potential product rationalization wave. Insider trading activity is limited, but the 15.4% stake build-up in TMT India via an open offer is notable. Capital allocation is mixed, with Denali Therapeutics generating $195M from a PRV sale, while T1 Energy takes on $133M in debt for IP acquisition.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — July 28, 2026

Today's digest (July 28, 2026) reveals a market bifurcated between operational strength and significant one-time charges. UPS and Polaris posted strong revenue growth but saw GAAP earnings depressed by transformation and tariff-related costs, while Centene and Hilton delivered clean beats with raised guidance. The healthcare sector saw major legal overhang removal (J&J's $5.5B talc settlement) and a large PRV monetization (Denali's $195M sale), but also a clinical-stage biotech IPO (Scribe Therapeutics) and mixed Alzheimer's data (ProMIS). A notable negative signal emerged from Rexford Industrial, which posted a massive $624.8M impairment-driven loss, and from the delisting of Vestand. Insider selling was concentrated at Celsius Holdings (two directors sold ~$13.9M combined) and Sea Ltd's COO ($1.5M sale), while capital allocation remained aggressive with Armstrong World Industries authorizing an $800M buyback and Bread Financial growing credit sales 11% YoY. The overarching theme is one of 'quality over quantity'—companies with pricing power and clean balance sheets are outperforming, while those reliant on one-time benefits or facing structural headwinds are being penalized.

24 high priority 26 medium 50 total filings
· daily

US Earnings Financial Results SEC Filings — July 28, 2026

The Q2 2026 earnings season reveals a bifurcated market where revenue growth is often decoupled from profitability. While 60% of reporting companies (30/50) show top-line expansion, margin compression is a dominant theme, with 14 companies reporting declining net income despite higher revenues, driven by rising costs, impairments, and acquisition-related charges. The most significant capital allocation trend is aggressive share repurchase activity, with at least 8 companies spending over $1B combined on buybacks, signaling management confidence but also contributing to declining cash reserves. The healthcare and industrial sectors show the strongest momentum, with Abbott Laboratories, Incyte Corp, and Steel Dynamics posting exceptional growth, while the energy and real estate sectors face headwinds from asset impairments and rising interest expenses. A notable development is the surge in M&A activity, with Element Solutions agreeing to be acquired and Abbott completing a $20B acquisition, suggesting a wave of consolidation. Insider trading data is sparse, but the absence of significant insider selling in the face of strong buyback programs is a positive signal. The overall sentiment is cautiously optimistic, with a focus on companies that can demonstrate both revenue growth and margin expansion.

50 high priority 50 total filings
· daily

US IPO Pipeline SEC S-1 Filings — July 28, 2026

Both filings in today's IPO pipeline digest reveal a stark pattern of micro-cap distress, with two Nasdaq-listed companies (Polar Power and Sadot Group) filing S-1 registration statements for resale of common stock amid severe financial challenges. Period-over-period data shows Polar Power's stockholders' equity improved from ~$0.1M (Dec 2025) to $2.3M (Mar 2026), a massive 2,200% QoQ increase, yet still below the $2.5M minimum, while Sadot Group claims equity has been restored to over $7M through an acquisition and other measures, though audited financials are pending. Both companies face Nasdaq non-compliance letters—Polar Power received one on May 1, 2026, and Sadot on May 5, 2026—and both carry going concern qualifications from their auditors. The most critical development is the operational instability at Polar Power, which was evicted from its headquarters on May 19, 2026, and lost two independent directors, signaling deep governance and liquidity crises. The portfolio-level theme is that these are not traditional IPOs but rather distressed resale registrations, where selling stockholders (including a committed equity facility provider) seek to exit positions, making these filings a red flag for retail investors rather than a pipeline of new growth stories.

2 high priority 2 total filings
· daily

USA Institutional Investor Activity — July 28, 2026

W.G. Shaheen & Associates DBA Whitney & Co filed its Q2 2026 13F-HR on July 28, 2026, revealing a concentrated, mega-cap-centric long equity portfolio with top holdings in Apple, NVIDIA, Alphabet, Amazon, and Newmont Corp. The filing is a static snapshot as of June 30, 2026, and lacks aggregate portfolio NAV or total value, preventing precise period-over-period percentage comparisons at the portfolio level. However, the disclosed share counts and the presence of both net increases and decreases in positions (via 'VOTING AUTH/OTHER' fields) indicate active portfolio rebalancing during the quarter. The firm's heavy weighting in technology and AI-exposed names (Apple, NVIDIA, Alphabet, Amazon) suggests a bullish tilt toward secular growth themes, while a significant position in gold miner Newmont Corp introduces a defensive/commodity hedge. No forward-looking guidance, insider transactions, or capital allocation actions are present in this filing type, limiting forward-looking insights. The key takeaway is a high-conviction, large-cap growth portfolio with a notable commodity hedge, reflecting a cautious optimism on tech leadership while hedging against macro uncertainty.

1 medium 1 total filings
· daily

US SEC Trading Suspension Halt Orders — July 28, 2026

The two filings in this stream highlight acute regulatory and financial distress within the US-listed equity space, specifically concerning Nasdaq listing compliance. Vestand Inc. (VSTD) has been delisted effective July 27, 2026, due to multiple reporting failures and governance concerns, representing a terminal event for its exchange listing. In contrast, Blink Charging Co. (BLNK) has received a second 180-day extension to cure its bid price deficiency, providing a temporary reprieve but with a high risk of eventual delisting. The overarching theme is a bifurcation between companies that have exhausted their compliance options (Vestand) and those on a final watch (Blink Charging). No period-over-period financial trends or insider activity were available in the enriched data, but the forward-looking data for Blink Charging explicitly flags a potential reverse stock split as a cure, a common but often value-destructive last resort. The market implications are clear: investors should avoid Vestand shares on the OTC market and monitor Blink Charging closely for a potential dilutive event or a final delisting notice in early 2027.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — July 28, 2026

The 26 filings reveal a period of significant leadership transition across US equities, with a notable concentration of CEO and CFO changes in the technology and industrial sectors. The most critical development is the sudden and unexpected passing of Carpenter Technology's CEO, triggering an immediate and high-materiality leadership crisis. While most changes are routine retirements or planned successions, a pattern of CFO departures emerges, particularly at smaller-cap firms like Satellogic and Unicoin, where successors are not yet named, creating operational risk. The data shows a mix of internal promotions and external hires, with compensation packages heavily weighted toward equity incentives, especially in high-growth sectors. From the limited period-over-period data available, Centene's strong operational turnaround (EPS swing from -$0.51 to $2.19) stands out as a positive signal, while the broader trend of declining membership in managed care raises a cautionary flag. Overall, the digest points to a market where leadership stability is a key differentiator, and sudden departures present both risks and opportunities for investors.

26 high priority 26 total filings
· daily

US Corporate Board Director Changes SEC Filings — July 28, 2026

The 26 filings reveal a significant wave of boardroom changes across US equities, characterized by a mix of routine successions, sudden leadership voids, and strategic appointments. A critical theme is the high materiality of unexpected CEO departures, notably the sudden passing of Carpenter Technology's CEO, which creates immediate leadership risk. Conversely, several companies are making strategic board appointments with deep industry expertise, such as Haemonetics and Bicara Therapeutics, signaling a focus on operational and commercial execution. The data shows a clear pattern of internal promotions for key roles (e.g., Valmont, Kennametal) alongside external hires for specialized expertise (e.g., Bark, ZipRecruiter). While most filings lack direct financial period-over-period comparisons, the one filing with such data (Centene) shows a dramatic turnaround from a GAAP loss to profitability, providing a strong positive signal. The overall sentiment is neutral, but the actionable intelligence lies in identifying the companies with high materiality events and strategic board enhancements that could drive future performance. The most critical developments are the CEO succession at Carpenter Technology and the strategic board appointments at Bicara Therapeutics and Haemonetics, which have the highest potential for market impact.

26 high priority 26 total filings
· daily

USA Insider Trading Pulse — July 28, 2026

The July 28, 2026 insider trading pulse reveals a quiet but notable day dominated by routine equity compensation awards at Japanese mega-banks Mizuho and Sumitomo Mitsui, alongside a few significant open-market sales and tax-withholding events that warrant attention. The most actionable signal is the coordinated $20.8M sale by three Celsius Holdings directors at $46.25, which, while potentially part of a pre-arranged plan, represents a material reduction in insider holdings. A contrasting bearish signal comes from Sea Ltd, where the COO sold $1.5M under a 10b5-1 plan, and from BancFirst, where a director sold $3.46M in a single transaction. The Progressive Corp tax-withholding sales ($2.4M combined) are routine but reflect high insider equity exposure. The 30+ Mizuho phantom stock awards and 15+ SMFG stock awards/issuer dispositions are overwhelmingly neutral, reflecting standard compensation cycles. A single small buy ($2.3K) at RENN Fund by a 10% owner provides a faint bullish signal. The overall theme is one of routine corporate governance activity punctuated by a few high-conviction insider sales that investors should monitor for follow-up.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — July 28, 2026

The July 28, 2026 M&A landscape is dominated by SPAC activity (5 of 11 filings) and transformative healthcare/energy transactions. The most material event is the Yarrow-VYNE merger, a $200M-backed biotech roll-up with a mixed outlook due to severe dilution for legacy shareholders. In the energy sector, T1 Energy's $135M patent acquisition from Evervolt strengthens its vertical integration but carries acute financing risk with $133M due by October. The student housing sector shows strong fundamentals with Core University Living's $303.5M portfolio acquisition 99.4% pre-leased. The Cross Country Healthcare privatization by Knox Lane marks a significant healthcare staffing exit from public markets. A key period-over-period trend is the continued use of SPACs as a capital-raising vehicle, with $315M in new SPAC IPOs this week alone. Insider activity is minimal, but the VYNE special dividend ($17.3M) and deferred compensation structures at Charlton Aria signal careful capital management. The EchoStar $2.4B Wireless Creditor Trust represents a unique regulatory-driven M&A structure tied to FCC approvals.

11 high priority 11 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 28, 2026

Overnight filings paint a bifurcated picture: robust operational performance at blue-chips like UPS, Hilton, and CenterPoint Energy is being masked by significant one-time transformation costs (UPS) or non-operating losses (CenterPoint), creating potential value dislocations. The IPO of Scribe Therapeutics ($SCTX) at $15.00 is the most prominent capital markets event, with strong insider buying at the offer price signaling management conviction. A wave of insider option awards and stock grants at Scribe, SharpLink Gaming, and 5C Lending Partners suggests a focus on long-term incentive alignment. Conversely, a major insider sale at United Therapeutics and a 10% owner sale at Actelis Networks flash caution. The pending mega-merger between Axalta and AkzoNobel is progressing, with Axalta reporting record-low leverage. Key themes include a 'show-me' growth story at UPS, a strong travel demand signal from Hilton, and a significant order win for Ceragon in India.

33 high priority 17 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — July 27, 2026

The July 27, 2026, batch of filings for the S&P 500 Technology sector reveals a clear bifurcation between management teams. At Datadog, a significant insider selling event by both a Director and the CEO, totaling over $8.5 million, sends a strong negative signal on valuation, despite being executed under 10b5-1 plans. Conversely, Intuit is aggressively investing in its leadership team with a massive equity grant to its CEO and substantial RSU awards to its CFO and other key executives, signaling a long-term focus on retention and performance. A passive 9.4% stake disclosure by BlackRock in Adobe confirms institutional confidence but lacks a catalyst for change. A single insider sale at Micron Technology, while small in volume, occurs at a high absolute price of $1,000, potentially indicating a perceived top. The absence of any operational or financial performance data in the Cadence 8-K filing limits its utility for trend analysis. The dominant theme is a divergence in insider behavior: concentrated selling in high-growth software (Datadog) versus heavy equity-based compensation and retention in established platforms (Intuit).

8 high priority 2 medium 10 total filings
· daily

Nasdaq 100 Stocks SEC Filings — July 27, 2026

The July 27, 2026, filing batch for the NASDAQ-100 is dominated by a massive, coordinated equity compensation event at **Intuit Inc.**, where the CEO and four other top executives were awarded a combined ~305,000+ restricted stock units and options. This event, while routine, signals a strong retention and alignment strategy from the board, locking in key leadership through performance-based vesting. In contrast, **Micron Technology** shows a bearish insider signal, with its Chief Accounting Officer selling nearly $879K in stock at a high price point. **Strategy Inc** (formerly MicroStrategy) continues its aggressive capital market strategy, raising $544.5M via common stock ATM sales while holding its massive $63.69B Bitcoin treasury static, indicating a pause in accumulation. **Adobe** and **Intuitive Surgical** filings are procedural (passive ownership disclosure and bylaw amendments) and carry low materiality. The dominant theme is a divergence in insider behavior: heavy, structured insider awards at Intuit versus a direct cash-out at Micron, alongside Strategy Inc's relentless equity dilution to fund its Bitcoin strategy. No period-over-period comparisons or forward-looking guidance were available in these specific filings, limiting trend analysis to insider activity and capital allocation patterns.

7 high priority 2 medium 9 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — July 27, 2026

This digest of 50 SEC filings reveals a surge in activist and institutional activity, with two distinct themes dominating: aggressive proxy fights in small-cap biotech/tech and a massive wave of passive institutional position disclosures from JPMorgan, BlackRock, and First Trust. The most critical development is the escalated proxy fight at Evogene Ltd., where a 17.4% shareholder group has set a hard July 31 deadline to call a special meeting, threatening personal director liability. Concurrently, a consortium including CPPIB has submitted a revised $7.02/share best-and-final offer for ReNew Energy Global, signaling a potential take-private. On the passive side, JPMorgan disclosed significant 5%+ stakes in 12 companies, including a 13% position in DigitalOcean and 9.8% in Burlington Stores, while BlackRock revealed a 13.7% stake in Concentra Group and 11.2% in Crescent Energy. A notable pattern emerges from Orin Hirschman's AIGH Capital, which filed 8 new passive 13G positions across small-caps while completely exiting Intellicheck, suggesting a portfolio rotation into value-oriented micro-caps. The most bearish signal is BlackRock's massive 70%+ reduction in Beyond Meat, dropping from a 5%+ holder to just 1.5%, signaling a loss of conviction in the plant-based meat sector.

6 high priority 44 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — July 27, 2026

This digest covers 5 filings from S&P 500 Financials constituents, all with enriched insider trading data. A notable cluster of insider selling is evident, with high-level executives at Travelers (2 EVPs), Progressive (CIO), and Truist (Director) all reducing equity exposure. The lack of any buy-side activity paints a uniformly bearish insider sentiment across the subsector, suggesting management may see current valuations as full or headwinds building at the company level. In isolation, Travelers’ two distinct insider sales (both C-suite, totaling ~$4.4M) are the most material events, as they are linked to option exercises and multi-million dollar share disposals. The Goldman Sachs preferred stock filing (Series AA) is capital-neutral but adds fixed-income supply, pointing to ongoing balance-sheet management. No period-over-period comparisons, forward-looking guidance, or capital allocation changes were present in the enriched data, limiting sector-wide trend analysis. Overall, the dominant theme is insider de-risking by bank and insurance executives, which warrants close monitoring for further signs of fundamental deterioration.

5 high priority 5 total filings
· daily

S&P 500 Energy Sector SEC Filings — July 27, 2026

The S&P 500 Energy sector is showing a bifurcated picture: Baker Hughes (BKR) demonstrates robust operational execution in its Industrial & Energy Technology (IET) segment, with record orders and RPO, yet faces headwinds from declining GAAP earnings and flat OFSE backlog, resulting in a mixed sentiment. Expand Energy's acquisition of Twin Eagle signals strategic consolidation in the midstream space, though the lack of financial details creates uncertainty. Insider activity is minimal, with only a nominal buy at Texas Pacific Land Corp (TPL), but a significant passive stake accumulation by JPMorgan in BKR (6.9%) suggests institutional confidence. Period-over-period data reveals margin improvement at BKR (adjusted EBITDA +6% QoQ) despite revenue declines, pointing to cost discipline. The sector's capital allocation focus remains on growth investments (BKR's RPO surge) and strategic M&A (Expand Energy), with no dividend or buyback changes noted in the filings. The key portfolio-level theme is the divergence between traditional oilfield services (flat/declining) and energy transition/industrial technology (strong growth), which investors should monitor for relative performance.

2 high priority 3 medium 5 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — July 27, 2026

The three Consumer Staples filings reveal a sector bifurcated between defensive insider buying and governance tightening. McCormick's director purchase signals confidence in the non-voting share class at a $50.21 entry point, contrasting with Hershey's 10% owner executing a routine $1.4M sale under a 10b5-1 plan, which is a neutral-to-negative signal given the trust's structural selling. Kraft Heinz's bylaw amendments raising the special meeting threshold to 20% represent a defensive governance move to insulate management from activist pressure, a growing trend in the sector. No period-over-period financial trends or forward-looking guidance were disclosed in these filings, limiting trend analysis. The key actionable insight is the divergence in insider behavior: McCormick's director is betting on value, while Hershey's largest holder continues a pre-planned liquidation. The sector's capital allocation and operational metrics remain opaque from these specific filings, but the governance shift at Kraft Heinz warrants monitoring for potential shareholder activism.

3 high priority 3 total filings